Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01925573
Title NOVOTTF-100A+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Maryland
Indications

glioblastoma

high grade glioma

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.